跳至主要内容
临床试验/NCT07478367
NCT07478367招募中不适用

Critical Illness Weakness Outside the Intensive Care Unit. A Prospective Cohort Study.

Istituto Clinico Humanitas1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年11月18日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
Incidence of CRIMYNE-like neuromuscular involvement

研究概览

简要总结

When people become seriously ill, their bodies can be affected in many ways beyond the original disease. One well-known complication in patients treated in intensive care units (ICUs) is the development of severe muscle weakness caused by damage to muscles and nerves. This condition is called critical illness-related weakness and includes disorders of the nerves (neuropathy), the muscles (myopathy), or both. These problems can make it difficult for patients to move, walk, or even breathe independently, and recovery can take months or longer.

So far, most research on this type of weakness has focused on patients who were treated in ICUs. However, many hospitalized patients outside the ICU-such as those admitted to internal medicine wards or semi-intensive care units-can also experience severe infections, organ failure, inflammation, prolonged bed rest, and metabolic stress. These are the same risk factors known to cause nerve and muscle damage in ICU patients. Despite this, weakness occurring outside the ICU is often overlooked, attributed simply to "deconditioning" or prolonged bed rest, and not properly investigated.

The CRI-WEAK-OUT study aims to better understand whether critical illness-related weakness also occurs in hospitalized patients who are not admitted to the ICU, how often it happens, how severe it is, and what factors increase the risk of developing it.

This is a prospective observational study, meaning that patients will be followed over time during and after their hospital stay, without changing their usual medical care. The study will include about 600 adult patients hospitalized for acute illnesses in non-ICU wards across several Italian hospitals. Half of the participants will have signs of organ failure during hospitalization, while the other half will serve as a comparison group without organ failure.

All participants will undergo careful clinical evaluations shortly after hospital admission and again before discharge. Doctors will assess muscle strength, level of disability, independence in daily activities, and overall frailty using standardized and widely accepted scales. Six months after discharge, patients will be contacted by phone to evaluate their recovery and quality of life.

If a patient develops new or worsening muscle weakness during hospitalization, more detailed tests will be performed. These include electrical tests of nerves and muscles to understand whether the weakness is caused mainly by nerve damage, muscle damage, or both. In a subgroup of patients, additional blood samples will be collected to measure substances linked to inflammation and nerve injury. These biological markers may help doctors recognize the condition earlier and predict recovery.

By collecting detailed clinical, electrical, and biological information, the study aims to answer several important questions:

  • How common is critical illness-related weakness outside the ICU?
  • Which patients are most at risk?
  • How does this condition affect recovery and long-term independence?
  • Can blood markers help identify patients with nerve or muscle damage? The results of the CRI-WEAK-OUT study may improve awareness of this under-recognized condition, promote earlier diagnosis, and help clinicians plan better prevention and rehabilitation strategies. Ultimately, this research could lead to improved care, faster recovery, and better quality of life for many hospitalized patients who currently experience unexplained weakness after acute illness.

详细描述

Critical illness myopathy and neuropathy (CRIMYNE) is a spectrum of neuromuscular disorders that develop in patients with severe systemic illness and includes critical illness polyneuropathy, critical illness myopathy, and overlapping forms. These conditions are characterized by generalized symmetrical weakness involving limb and respiratory muscles and typically emerge during or after a prolonged critical illness. CRIMYNE is associated with prolonged mechanical ventilation, extended hospital stays, increased mortality, and long-term disability.

Although CRIMYNE has been primarily described in patients admitted to intensive care units (ICUs), many of the risk factors associated with its development-including systemic inflammation, sepsis, metabolic disturbances, hyperglycemia, prolonged immobilization, and multiorgan dysfunction-are also present in patients hospitalized in internal medicine wards or semi-intensive care settings. Despite this overlap, neuromuscular weakness related to acute illness in non-ICU patients remains poorly recognized and is often attributed to nonspecific causes such as general deconditioning or prolonged bed rest.

It is plausible that neuromuscular involvement similar to CRIMYNE may occur outside the ICU in patients experiencing acute illness with systemic stress and organ dysfunction. However, this condition may be underdiagnosed in non-ICU environments due to limited awareness, competing clinical priorities, and potentially milder clinical manifestations. A better understanding of the occurrence, clinical characteristics, and outcomes of CRIMYNE-like neuromuscular involvement in non-ICU hospitalized patients could improve recognition of this condition, facilitate earlier diagnosis, and support the development of preventive and rehabilitation strategies.

This study is a prospective cohort study including hospitalized adult patients admitted to non-ICU hospital units for acute medical conditions. Participants will be evaluated during hospitalization and followed longitudinally to investigate the occurrence of neuromuscular weakness compatible with CRIMYNE-like involvement.

Participants will undergo clinical evaluation at baseline, within 48 hours of hospital admission, and again near the time of discharge. Muscle strength, disability, and frailty will be assessed using standardized clinical scales. A follow-up evaluation will be performed six months after hospital discharge to assess functional outcomes and quality of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Hospitalization for acute illness in a non-ICU unit
  • For the critical illness cohort: presence of organ failure defined as a SOFA score ≥ 2 at admission or an increase (ΔSOFA) ≥ 2 during hospitalization
  • For the control cohort: SOFA score < 2 throughout hospitalization
  • Ability to provide written informed consent

排除标准

  • History of peripheral neuropathy, myopathy, or other neuromuscular disorders (e.g., myasthenia gravis)
  • Conditions affecting the lower limbs that prevent electrophysiological testing
  • Delirium with agitation preventing clinical evaluation
  • Coma or inability to assess muscle strength

研究组 & 干预措施

control group

Hospitalized non-ICU patients with acute illness without organ failure, defined as a SOFA score < 2 throughout hospitalization.

干预措施: No Intervention: Observational Cohort (Other)

study group

Hospitalized non-ICU patients with acute illness and organ failure, defined as a SOFA score ≥ 2 or an increase (ΔSOFA) ≥ 2 during hospitalization.

干预措施: No Intervention: Observational Cohort (Other)

结局指标

主要结局

Incidence of CRIMYNE-like neuromuscular involvement

时间窗: At hospital discharge

Presence of new-onset weakness (yes/no)

次要结局

  • Electrophysiological evidence of CRIMYNE-like neuromuscular involvement(At hospital discharge)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验